Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 200 of 2228 entries
View as:

Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone

Phase: N/A Priority: Normal
NCT ID: NCT00641043 Org: User:
Start: 03/31/08 End: - Due: -

Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01022853 Org: User:
Start: 12/31/09 End: 02/28/13 Due: 02/28/14

Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known

Phase: N/A Priority: Normal
NCT ID: NCT01971476 Org: User:
Start: 10/22/13 End: 01/27/17 Due: 01/27/18

Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00239460 Org: User:
Start: 07/31/03 End: - Due: -

A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination

Phase: N/A Priority: Normal
NCT ID: NCT02606877 Org: User:
Start: 04/19/16 End: 03/22/17 Due: 03/22/18

Comparative Effectiveness of Oral Anticoagulants

Phase: N/A Priority: Normal
NCT ID: NCT01847547 Org: User:
Start: 04/30/13 End: 04/30/13 Due: 04/30/14

BI 671800 in Asthmatic Patients on Inhaled Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT01103349 Org: User:
Start: 04/20/10 End: 08/09/11 Due: 08/09/12

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183298 Org: User:
Start: 05/31/06 End: - Due: -

Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

Phase: N/A Priority: Normal
NCT ID: NCT01108809 Org: User:
Start: 04/30/10 End: - Due: -

Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02251223 Org: User:
Start: 02/28/01 End: - Due: -

Pharmacokinetics and Safety Study of BI 695501 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01505491 Org: User:
Start: 12/01/11 End: 07/01/12 Due: 07/01/13

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183545 Org: User:
Start: 07/31/14 End: 10/31/14 Due: 10/31/15

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Phase: N/A Priority: Normal
NCT ID: NCT04180813 Org: User:
Start: 03/04/20 End: 07/11/21 Due: 07/11/22

Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00681863 Org: User:
Start: 05/31/08 End: - Due: -

Study to Assess the Kinetic of the Analgesic Effect and Tolerability of Eschscholtzia Californica Versus Ibuprofen and Placebo in the Treatment of Pain After Surgery of the Third Molar

Phase: N/A Priority: Normal
NCT ID: NCT02187588 Org: User:
Start: 02/28/98 End: - Due: -

Characteristics of Empagliflozin Initiators

Phase: N/A Priority: Normal
NCT ID: NCT03050619 Org: User:
Start: 09/10/16 End: 10/14/16 Due: 10/14/17

General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00319813 Org: User:
Start: 04/19/06 End: 09/05/07 Due: 09/05/08

Tolerability and Safety of Duloxetine BID in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02232542 Org: User:
Start: 06/30/03 End: - Due: -

BI 671800 ED in Steroid-naive Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01092143 Org: User:
Start: 03/18/10 End: 03/26/11 Due: 03/26/12

CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT04860830 Org: User:
Start: 08/09/21 End: 11/20/24 Due: 11/20/25

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]

Phase: N/A Priority: Normal
NCT ID: NCT02780700 Org: User:
Start: 07/05/16 End: 09/09/16 Due: 09/09/17

A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032

Phase: N/A Priority: Normal
NCT ID: NCT04086121 Org: User:
Start: 09/24/19 End: 02/23/22 Due: 02/23/23

Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03123185 Org: User:
Start: 04/27/17 End: 02/19/18 Due: 02/19/19

Relative Bioavailability of BI 10773 and Glimepiride in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02172261 Org: User:
Start: 04/30/09 End: - Due: -

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)

Phase: N/A Priority: Normal
NCT ID: NCT00152958 Org: User:
Start: 01/31/04 End: - Due: -